Bcal Diagnostics Ltd (BDX) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.999x

Based on the latest financial reports, Bcal Diagnostics Ltd (BDX) has a cash flow conversion efficiency ratio of -0.999x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.50 Million ≈ $-1.77 Million USD) by net assets (AU$2.50 Million ≈ $1.77 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see BDX market cap for the company's overall valuation and market capitalisation.

Bcal Diagnostics Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Bcal Diagnostics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bcal Diagnostics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bcal Diagnostics Ltd ranked by their cash flow conversion efficiency. See BDX operating cash to total liabilities to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Victor Group Holdings Ltd AU:VIG	0.072x
Eastparc Hotel Tbk PT JK:EAST	0.017x
Outback Goldfields Corp V:OZ	-0.020x
Diamond Citra Propertindo PT JK:DADA	0.018x
Secuve Co. Ltd KQ:131090	0.065x
Europa Metals Ltd JSE:EUZ	-0.110x
Acrinova AB Series B ST:ACRI-B	0.092x
Podium Minerals Ltd AU:POD	-0.035x

Annual Cash Flow Conversion Efficiency for Bcal Diagnostics Ltd (2017–2024)

The table below shows the annual cash flow conversion efficiency of Bcal Diagnostics Ltd from 2017 to 2024. View Bcal Diagnostics Ltd (BDX) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AU$6.22 Million ≈ $4.40 Million	AU$-6.14 Million ≈ $-4.34 Million	-0.986x	-87.28%
2023-12-31	AU$8.59 Million ≈ $6.08 Million	AU$-4.52 Million ≈ $-3.20 Million	-0.527x	+54.60%
2022-12-31	AU$5.21 Million ≈ $3.69 Million	AU$-6.05 Million ≈ $-4.28 Million	-1.160x	-247.35%
2021-12-31	AU$9.64 Million ≈ $6.82 Million	AU$-3.22 Million ≈ $-2.28 Million	-0.334x	+0.16%
2020-12-31	AU$3.61 Million ≈ $2.55 Million	AU$-1.21 Million ≈ $-853.62K	-0.334x	+77.81%
2019-12-31	AU$438.92K ≈ $310.56K	AU$-661.65K ≈ $-468.16K	-1.507x	-40.18%
2018-12-31	AU$488.20K ≈ $345.43K	AU$-525.01K ≈ $-371.48K	-1.075x	-118.70%
2017-12-31	AU$-81.85K ≈ $-57.91K	AU$-470.81K ≈ $-333.13K	5.752x	--

About Bcal Diagnostics Ltd

AU:BDX Australia Diagnostics & Research

Market Cap

$22.43 Million

AU$31.71 Million AUD

Market Cap Rank

#24926 Global

#1033 in Australia

Share Price

AU$0.09

Change (1 day)

+22.86%

52-Week Range

AU$0.05 - AU$0.14

All Time High

AU$0.25